Issuu

Rocky Mountain Sarcoma Symposium

Rocky Mountain Sarcoma Symposium

Faculty

Thank You to Our Esteemed Faculty

We are thrilled to welcome you to the Rocky Mountain Sarcoma Symposium in beautiful Boulder, Colorado. This year ' s program emphasizes clinical treatment and clinical trial updates in multidisciplinary sarcoma care. We are honored to feature an impressive lineup of lecturers from the University of Colorado, as well as nationally-known guest lecturers.

We extend our heartfelt gratitude to all the faculty members who have dedicated their time and expertise to make this event possible. Your commitment to advancing sarcoma care through clinical excellence and groundbreaking research is truly inspiring. Thank you for your invaluable contributions and for being a beacon of hope for patients and families affected by sarcoma.

Steven Thorpe, MD Co-Director

Breelyn Wilky, MD Co-Director

Kaled Alektiar, MD

Erica Becker, PA Committee Member

Emily Blauel, MD Committee Member

Michael Clay, MD Committee Member

Sandra D’Angelo, MD Jenna Demedis, MD, MS Committee Member

Nathan Donaldson, DO Committee Member

Richard Gorlick, MD

Masanori Hayashi, MD Committee Member

Ryan Lanning, MD, PhD Committee Member

Bennie Lindeque, MD, PhD

Martin McCarter, MD

Alex Merkle, MD Committee Member

Sarah Milgrom, MD

Lor Randall, MD

Daniel Regan, DVM, PhD Jason Sicklick, MD

CME Accreditation - Rocky Mountain Sarcoma Symposium

The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians

The University of Colorado School of Medicine designates this live activity for a maximum of 8.0

AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Relevant Financial Relationships

Alessandra Maleddu, MD: Advisor for Springworks*, Deciphera

Alexander Merkle, MD: Consultant for Spinecamp.ai

Breelyn Wilky, MD: Consultant for Deciphera, Boehringer Ingelheim, AADI Bioscience

Steven W. Thorpe, MD: Advisor and Consultant for Deciphera

Sandra D'Angelo, MD: Consultant for Adaptimune, Medendi*, Ratio Therapies, Replimune; Independent Contractor for Piper and Sandler

Jason Sicklick, MD: Advisor for Curematch; Consultant and Speaker for Deciphera; Consultant for Kura; Stock Holder with Personalis;

Richard Gorlick, MD: Advisor for Recordati*, EMD Serono*, Arcus Biosciences*, Jazz Pharmaceuticals*, Abbvie*

*Denotes the relationship has ended

All of the relevant financial relationships listed for these individuals have been mitigated.

All other planners, faculty, or individuals in control of content for this educational activity have no relevant financial relationships to disclose with ineligible companies.

An ineligible company is any entity whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Relevant financial relationships are financial relationships of any amount occurring in the past 24 months with ineligible companies if the educational content an individual can control is related to the business lines or products of the ineligible company

INNOVATION, COLLABORATION, AND HOPE

The CU Sarcoma program is looking to harness the tremendous strengths of the CU Anschutz campus, uniting sarcoma experts at Children’s Hospital Colorado, the CU Cancer Center, and the University of Colorado Hospital

We are striving to build the preferred sarcoma center in the Rocky Mountain Region with national reach that is offering hope through clinical trials, collaboration, and advancing research at world class research facilities and unique collaborations with the CU Boulder campus and The CSU Flint Cancer Center

Steven Thorpe, MD

Associate Professor Chief | Musculoskeletal Oncology

6:30 am – 7:00 am

7:00 am – 7:10 am

7:10 am – 7:55 am

7:55 am – 8:15 am

8:15 am – 8:35 am

8:35 am – 8:55 am

8:55 am – 9:15 am

9:15 am – 9:35 am

9:35 am – 9:50 am

Registration & Breakfast

Welcome & Opening Remarks

Steven W. Thorpe, MD and Breelyn A. Wilky, MD

9:50 am – 10:05 am

PEDIATRIC AND AYA SARCOMA

What’s on the Horizon for Osteosarcoma Systemic Treatment?

Richard Gorlick, MD

Radiation Therapy in Pediatric STS: How Has ARST 0332 Shaped Its Use?

Sarah Milgrom, MD

Heavy Metal versus Biologic Reconstructions in Pediatric Sarcoma

Nathan Donaldson, DO

Molecular Targeted Therapy in Pediatric Sarcoma

Emily Blauel, MD

Liquid Biopsies: Ready for Clinical Application?

Masanori Hayashi, MD

From Dog to Human: Developing Novel Treatments for Osteosarcoma

Dan Regan, DVM, PhD

Expert Panel Discussion/Q&A

Richard Gorlick, Mas Hayashi, Sarah Milgrom, Lor Randall, Nathan Donaldson, Jenna Demedis, Emily Blauel

Coffee Break

10:05 am – 10:50 am

10:50 am – 11:35 am

11:35 am – 11:55 am

11:55 am – 12:05 pm

12:05 pm – 12:50 pm

EXTREMITY AND TRUNCAL SARCOMA: DIAGNOSIS AND LOCAL CONTROL

Advances in the Surgical Treatment for Sarcoma: From Scalpel to Augmented Reality and Beyond

R. Lor Randall, MD

Hypofractionated Regimens: Weighing the Pros and Cons

Kaled Alektiar, MD

Molecular Highlights in Diagnosis of Sarcoma Pathology

Michael Clay, MD

Expert Panel Discussion/Q&A

Lor Randall, Kaled Alektiar, Ryan Lanning, Steven Thorpe

Lunch

12:50 pm – 1:35 pm

1:35 pm – 1:55 pm

1:55 pm – 2:25 pm

SYSTEMIC TREATMENT FOR SARCOMA

State of the Sarcoma: Immunotherapy for Sarcoma

Sandra D’Angelo, MD

Precision Sarcoma Treatment: Targets and Histologies

Breelyn Wilky, MD

Expert Panel Discussion/Q&A

Breelyn Wilky, Sandra D’Angelo

2:25 pm – 3:10 pm

3:10 pm – 3:30 pm

3:30 pm – 3:50 pm

3:50 pm – 4:00 pm

4:00 pm – 4:10 pm

RETROPERITONEAL SARCOMA AND GIST

GIST: Timing for Surgery After Neoadjuvant Treatment and Algorithms for Oligometastatic Resections

Jason Sicklick, MD

Updates on STRASS 1 and STRASS 2 for Retroperitoneal Sarcoma

Martin McCarter, MD

Radiation Treatment for Retroperitoneal Sarcoma

Ryan Lanning, MD

Expert Panel Discussion/Q&A

Breelyn Wilky, Jason Sicklick, Martin McCarter, Ryan Lanning

Closing Remarks

Bennie Lindeque, MD, PhD

Rocky Mountain Sarcoma Symposium

2025 Rocky Mountain Sarcoma Symposium

Rocky Mountain Sarcoma Symposium

Faculty

Thank You to Our Esteemed Faculty

INNOVATION, COLLABORATION, AND HOPE

PEDIATRIC AND AYA SARCOMA

Sponsors